The Business Brew cover image

Current Events - uniQure and the FDA

The Business Brew

00:00

Three-year results: clinical slowing signals

Sarah Tabrizi presents 36-month outcomes showing slower progression and supportive secondary endpoint trends.

Play episode from 31:23
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app